All In Biotech

Free tool

FAERS Monitor: Nuvessa

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 205223 or its brand name (Nuvessa, Metronidazole). Reports on generic versions are filed under their own applications.

Reports

48,241

Serious

42,012

87% of reports

Hospitalization

19,881

Death reported

5,419

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective4,672
  • nausea3,469
  • off label use3,384
  • diarrhoea2,721
  • vomiting2,342
  • pyrexia2,301
  • headache2,261
  • abdominal pain2,126
  • pain2,121
  • fatigue1,960
  • dizziness1,689
  • condition aggravated1,638
  • dyspnoea1,595
  • acute kidney injury1,545
  • malaise1,468

Reports by year received

View as table
YearReports
2004459
2005480
2006482
2007511
2008320
2009676
2010858
20111,164
20121,431
20131,112
20141,451
20152,167
20162,469
20172,511
20184,196
20194,496
20203,830
20213,904
20223,418
20233,478
20243,179
20253,456
20262,190

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,005,918 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
acute kidney injurySignal1,5454.44.24,097
abdominal painSignal2,1264.03.84,814
pyrexiaSignal2,3012.92.82,916
condition aggravatedSignal1,6382.42.21,289
vomitingSignal2,3422.22.11,517
nausea3,4691.91.91,568
diarrhoea2,7211.81.81,074
off label use3,3841.71.6985
headache2,2611.61.5486
drug ineffective4,6721.51.5962
pain2,1211.51.4371
dizziness1,6891.51.4266
malaise1,4681.51.4217
dyspnoea1,5951.21.270
fatigue1,9601.11.118

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.